Trends in Critical Care During Five COVID-19 Waves in Pakistan: Insights from a Multi-Center Observational Study by the Pakistan Registry of Intensive Care (PRICE) - Top-Institutions - MDSpire

Trends in Critical Care During Five COVID-19 Waves in Pakistan: Insights from a Multi-Center Observational Study by the Pakistan Registry of Intensive Care (PRICE)

  • By

  • Aasma Khan

  • Ahmed Nayeem

  • Nicole White

  • Ayesha Siddiqui

  • Arishay Hussaini

  • March 13, 2026

  • 0 min

Share

Top Institutions in Emergency Medicine

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Critical Care Medicine
    • Infectious Diseases
    • Epidemiology

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Critical Care Medicine
    • Pulmonary Medicine
    • Infectious Diseases

  • #3

    University of Oxford
    University of Oxford

    Oxford, N/A

    Key Differentiators

    • Critical Care Medicine
    • Epidemiology
    • Infectious Diseases

  • #4

    National Institute of Health (NIH)
    National Institute of Health (NIH)

    Bethesda, MD

    Key Differentiators

    • Critical Care Medicine
    • Infectious Diseases
    • Public Health

  • #5

    Aga Khan University
    Aga Khan University

    Karachi, Sindh

    Key Differentiators

    • Critical Care Medicine
    • Infectious Diseases
    • Public Health

Original Source(s)

Trends in Critical Care During Five COVID-19 Waves in Pakistan: Insights from a Multi-Center Observational Study by the Pakistan Registry of Intensive Care (PRICE)

  • by Aasma Khan, Ahmed Nayeem, Nicole White, Ayesha Siddiqui, Arishay Hussaini

  • March 13, 2026

Related Content

Raman Tool Opens the Door to Continuous Vaccine Manufacturing 

A confocal Raman microscope-based tool can characterize viral particles at-line and in real time

Equity and representation in oncology clinical evidence for FDA-approved treatments and the impact of COVID-19

Co-enrolment in critical care trials: a secondary analysis of the RECOVERY-RS trial